Previous 10 | Next 10 |
2024-03-09 03:59:00 ET Summary Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery. Biot...
2024-03-06 11:25:10 ET Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors, computer processing hardware and the computer peripherals industries. Additionally, the biotech sector is +13.6% in 2024, outdoing all of the major market aver...
2024-02-27 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-27 09:45:09 ET Gaotu Techedu Inc (GOTU) GOTU is trading UP for the last 5 days, and it at trading at $7.25 with volume of 14,422,277 and a one day change of $1.31 (22.05%). Gaotu Techedu Inc has a 52-week low of 2.22 and a 52-week high of $5.49. The business's 50-day moving ...
2024-02-23 04:05:00 ET Summary Within healthcare, an area that has been negatively impacted the last couple of years is the pharmaceutical manufacturing value chain. Several capital goods and materials sectors experienced recessionary conditions last year, which caused weak fundam...
2024-02-19 15:48:49 ET More on iShares Biotechnology ETF, iShares U.S. Medical Devices ETF, etc. XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance THQ Vs. XBI: Keeping The Biotech ETF For Now XBI: Biotech Speculation Top 10 ETFs...
2024-02-15 16:42:56 ET More on iShares Biotechnology ETF, SPDR S&P Biotech ETF, etc. THQ Vs. XBI: Keeping The Biotech ETF For Now XBI: Biotech Speculation Healthcare In 2024: Navigating The Biopharma Bull Run Biogen, Neurocrine, and more are Bairds top pi...
2024-02-15 02:00:00 ET Summary RGA Investment Advisors are an independent, fee-only investment management firm providing wealth management and financial planning for individuals, families, non-profit firms, and corporations of all sizes. Several significant trends that emerged in ...
2024-02-13 23:48:12 ET Summary The thirty-month bear market in biopharmaceutical stocks ended last October. The subsequent rally was standard, beginning with acquisitions at generous premiums. A mild correction followed in January. I believe that the next leg (the most profitable)...
2024-02-07 01:53:00 ET Summary A sub-$3trn 2023 for M&A, but new year pipeline gives hope. Rising follow-on equity in 2023 signals latent appetite. Unstoppable debt capital markets hit $8.9trn for FY2023. By Lucille Jones, Senior Manager, Deals Intelligence and...
News, Short Squeeze, Breakout and More Instantly...
SPDR Series Trust S&P Biotech Company Name:
XBI Stock Symbol:
NYSE Market:
2024-07-08 11:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 13:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...